Alexandra Latypova (Sasha) holds an MBA degree and is a former Pharmaceutical R&D Executive. Sasha spent approximately 25 years in the pharmaceutical industry. She has owned and managed several contract research organisations, conducting clinical trials for over 60 pharmaceutical clients worldwide. She became concerned about the irregularities, cover-up and apparent fraud relating to the extremely high number of deaths and injuries associated with the COVID-19 ‘vaccine’ rollout.
VISIONADOS DE LAS PRESENTACIONES DE
Pandemic Strategies: Lessons and Consequences – International Conference in Stockholm
No comments:
Post a Comment